Interestingly, PCYT2 promotes the interaction of PPP2R1A and PEBP1 and simultaneously reduces the binding of PPP2R1A and YAP1, leading to the enhancement of YAP1 phosphorylation, which in turn inhibits CRC cell migration and invasion. Here, PEBP1 is linked to colorectal carcinoma.